Skip to content

Efficacy Study of a Facemask Device to Treat Hypotension

Evaluation of an Inspiratory Impedance Threshold Device (ITD) in the Emergency Department for the Treatment of Hypotension

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00256724
Enrollment
47
Registered
2005-11-22
Start date
2005-06-30
Completion date
2008-01-31
Last updated
2013-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Keywords

hypotension, hypovolemia, dehydration, sepsis, blood loss

Brief summary

The purpose of this study is to determine if the impedance threshold device (ITD) attached to a facemask can increase blood pressure in patients who present to the emergency department with hypotension secondary to hypovolemia. The cause of hypovolemia could be blood loss, sepsis, or dehydration.

Detailed description

The study is designed to test the hypothesis that use of the ITD will result in a rapid rise in blood pressure secondary to an increase in cardiac output. Either an active or sham ITD will be applied to hypotensive patients when initially presented to the emergency department with a systolic blood pressure of \<95mmHg. The main endpoint of this study will be the rise in blood pressure over the first 10 minutes of use. Based upon pre-clinical studies as well as clinical studies performed to date, we hypothesize that use of the active ITD will result in a more rapid and higher blood pressure than the sham ITD. Multiple additional clinical parameters will also be compared between the two groups of patients.

Interventions

Active impedance threshold device

DEVICEsham ITD

sham impedance threshold device

Sponsors

United States Department of Defense
CollaboratorFED
Advanced Circulatory Systems
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Conscious patient * Systolic blood pressure \< 95 mmHg * Hypotension caused by blood loss, sepsis, or dehydration

Exclusion criteria

* Hypotension secondary to heart failure * Complaints of chest pain * History of heart failure * Complaints of shortness of breath

Design outcomes

Primary

MeasureTime frame
Rise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baselineevery 2 minutes during 10 minutes of device use

Secondary

MeasureTime frame
Quantity of Fluid Administrationduring 10 minutes of device use

Countries

United States

Participant flow

Recruitment details

Patients were recruited from the emergency department based on age (18-85)and systolic blood pressure ≤95mmHg who were conscious and presumed to have hypotension due to hypoivolemia or relative hypovolemia (blood loss, dehydration, or sepsis).

Participants by arm

ArmCount
Sham ITD
sham Impedance Threshold Device
23
Active ITD
active impedance threshold device
24
Total47

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision25
Overall StudyProtocol Violation33

Baseline characteristics

CharacteristicActive ITDSham ITDTotal
Age, Categorical
<=18 years
1 Participants0 Participants1 Participants
Age, Categorical
>=65 years
3 Participants3 Participants6 Participants
Age, Categorical
Between 18 and 65 years
20 Participants20 Participants40 Participants
Age Continuous46.8 years
STANDARD_DEVIATION 17.3
51.6 years
STANDARD_DEVIATION 11.8
49.1 years
STANDARD_DEVIATION 15
Region of Enrollment
United States
24 participants23 participants47 participants
Sex: Female, Male
Female
15 Participants13 Participants28 Participants
Sex: Female, Male
Male
9 Participants10 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 230 / 24
serious
Total, serious adverse events
0 / 230 / 24

Outcome results

Primary

Rise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baseline

Time frame: every 2 minutes during 10 minutes of device use

ArmMeasureValue (MEAN)Dispersion
Sham ITDRise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baseline5.9 mm HgStandard Deviation 5.9
Active ITDRise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baseline12.9 mm HgStandard Deviation 8.5
Secondary

Quantity of Fluid Administration

Time frame: during 10 minutes of device use

ArmMeasureValue (MEAN)Dispersion
Sham ITDQuantity of Fluid Administration175 mLStandard Deviation 197
Active ITDQuantity of Fluid Administration93 mLStandard Deviation 170

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026